After the Christmas festivities, the transmission of the Coronavirus remains upwards in Spain, with 292,394 contagions notified during the weekend and an increase in incidence at 14 days per 100,000 inhabitants of 267 points, up to 2,989 cases, figures that continue pushing The hospital pressure. According to the latest data offered this Monday by the Ministry of Health, the figure of Plant entered by Covid reaches up to 13.4%, while in the intensive units is 23.5%, very stressed in some regions Spanish for revenues by this virus.
The plan that the government lasts to address the Coronavirus as a common influenza has not quite covered in the three main primary care medical societies. If for one it is a precipitated decision that diffuses the magnitude of the disease "in an attempt to minimize the Covid", for others it is accurate because "gripalizing the attention" saves the system.
The latter is the opinion of the president of the Spanish Society of Family and Community Medicine (Semfyc), Salvador Tranche, who, in statements to EFE, argues that the current situation with a less pathogenic variant (omicron) and "excellent" rates of Vaccination allows you to change the strategy and pass "from a crisis management model to a control model".
Read here the complete information.
The research, published on Tuesday in the magazine 'Occupational & Environmental Medicine', indicates that there is a stronger link in the suspension particles, with an increase of 5% in the rate of infection with an average annual increase in a microgram by Cubic meter of this contaminant. This is equivalent to 294 additional cases per 100,000 people per year.
The study focuses on a locality from northern Italy, a region harshly hit by the pandemic of Coronavirus, with Lombardy as the area most affected in terms of cases and deaths. According to the European Environment Agency (EEA), most of the 3.9 million Europeans residing in areas where air pollution exceeds community boundaries live in northern Italy.
Recent research has involved contamination in the air as a risk factor for Covid-19 infection, but the design defects of the study and the capture of data only until mid 2020 have limited the findings, according to the researchers.
To solve these problems, they analyzed long-term exposure to air pollutants and covid-19 infection patterns since the beginning of the pandemic until March 2021 among the residents of Varese, the eighth largest city in Lombardy.
The European Medicine Agency (EMA) has begun to study the possibility of granting a European license to Paxlovid paste developed by Pharmaceutical Pfizer as treatment for patients over 12 years with Mild to moderate COVID-19. The European Agency already received the request from Pfizer for the European Commission to grant a conditional marketing authorization to its oral antiviral Paxlovid, intended for adults and adolescents over 12 years (who weigh at least 40 kilos) and suffer from Covid-19 Mild or moderate, but have a risk of progressing to a state of gravity.Updated Date: 11 January 2022, 01:14